The cost of the weight-loss drug is set to soar by 170pc, but there are steps you can take to mitigate the rise ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

Fact checked by Vikki Velasquez Key Takeaways Most underwriting forms don’t ask about GLP-1 drug use, creating blind spots for insurers as they price policies.Most patients stop GLP-1 drugs within a ...

Investing.com - TD Cowen has lowered its price target on Novo Nordisk (NYSE: NVO) to $70.00 from $105.00 while maintaining a Buy rating on the stock. The new target sits within the broader analyst ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...